Stevanato Group (STVN) news
Recent news
Tern - Announces settlement with general partner of SVV2 for all claims and liabilities
AInvest Wire · 2d agoSchott Pharma shares down 4.5% after Deutsche Bank cuts to hold from buy
Schott Pharma shares fell 4.5% on Wednesday following a downgrade from Deutsche Bank, which cut its recommendation to "hold" from "buy." The decline came amid broader concerns about the company's exposure to a single major customer and uncertainty over future demand for its products. The…
AInvest Wire · 5d agoStevanato Group SPA: Deutsche Bank initiates coverage with hold rating and target price $22
Deutsche Bank has initiated coverage on Stevanato Group S.p.A. (STVN) with a "hold" rating and a target price of $22, according to recent reports. The decision reflects an assessment of the company’s current market position and potential for growth. Stevanato Group, an Italian manufacturer of…
AInvest Wire · 7d agoEnergia launches alliance network with Shl Medical, Stevanato Group, Ypsomed, Argonaut and American Injectable
Energia has announced the formation of a strategic alliance network with five key players in the healthcare and pharmaceutical sectors: Shl Medical, Stevanato Group, Ypsomed, Argonaut, and American Injectable. The collaboration aims to enhance innovation, streamline supply chains, and improve…
AInvest Wire · Oct 1, 2026Stevanato Group SPA: UBS cuts target price to $23 from $28
AInvest Wire · Sep 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.